Want to see DANOY full AI Analyst Report?
DANOY Stock Chart & Stats
$15.00
$0.22(1.38%)
At close: 4:00 PM EDT
$15.00
$0.22(1.38%)
Day’s Range― - ―
52-Week Range$12.83 - $18.63
Previous CloseN/A
Volume319.42K
Average Volume (3M)690.23K
Market Cap
$44.01B
Enterprise Value$63.02B
Total Cash (Recent Filing)$8.34B
Total Debt (Recent Filing)$17.42B
Price to Earnings (P/E)19.9
Beta-0.20
Next Earnings
Feb 24, 2027EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend Yield3.83%
Share Statistics
EPS (TTM)0.61
Shares Outstanding3,416,685,800
10 Day Avg. Volume811,735
30 Day Avg. Volume690,227
Financial Highlights & Ratios
PEG Ratio-2.75
Price to Book (P/B)2.92
Price to Sales (P/S)1.81
P/FCF Ratio18.87
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue2.27
Enterprise Value/Gross Profit5.17
Enterprise Value/Ebitda13.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.89
Revenue Forecast (FY)$31.72B
Bulls Say, Bears Say
Bulls Say
Broad Organic GrowthBroad-based organic growth across categories and regions indicates improving demand for Danone’s health-focused portfolio. Reaffirmed full-year guidance also supports confidence that recent momentum can persist, while volume-mix gains suggest growth is not driven solely by pricing.
Specialized Nutrition StrengthStrong Medical Nutrition growth and faster expansion through hospitals, pharmacies, and home care reinforce Danone’s positioning in specialized, science-led categories. These channels can support more durable customer relationships and reduce reliance on mass retail demand alone.
Recurring Cash GenerationConsistently positive free cash flow provides internal funding for brands, innovation, acquisitions, and shareholder returns. Although 2025 momentum softened, the close relationship between cash flow and earnings supports the quality of reported profits and ongoing financial flexibility.
Bears Say
Weak Historical Revenue MomentumThe recent revenue record shows that Danone’s mature portfolio has not consistently converted its market presence into sustained top-line expansion. Even with improved current guidance, limited historical momentum can constrain operating leverage and make future growth more dependent on execution.
Moderate Debt CoverageLeverage appears manageable, but moderate operating-cash-flow coverage means debt paydown capacity is not especially strong. Persistent debt levels can limit capital allocation flexibility and leave less internally generated cash available for investment if earnings or cash conversion weaken.
North America EDP ConstraintsCompetitiveness issues and constrained yogurt capacity can delay recovery in an important category and region. Management expects additional production lines to help, but the stated timeline into 2027 indicates that operational remediation may weigh on growth and margins over the coming quarters.
DANOY FAQ
What was Danone SA ADR’s price range in the past 12 months?
Danone SA ADR lowest stock price was $12.83 and its highest was $18.63 in the past 12 months.
What is Danone SA ADR’s market cap?
Danone SA ADR’s market cap is $44.01B.
When is Danone SA ADR’s upcoming earnings report date?
Danone SA ADR’s upcoming earnings report date is Feb 24, 2027 which is in 125 days.
How were Danone SA ADR’s earnings last quarter?
Danone SA ADR released its earnings results on Jul 29, 2026. The company reported $0.437 earnings per share for the quarter, beating the consensus estimate of $0.429 by $0.008.
Is Danone SA ADR overvalued?
According to Wall Street analysts Danone SA ADR’s price is currently Overvalued.
Does Danone SA ADR pay dividends?
Danone SA ADR pays a Annually dividend of $0.527 which represents an annual dividend yield of 3.83%. See more information on Danone SA ADR dividends here
What is Danone SA ADR’s EPS estimate?
Danone SA ADR’s EPS estimate is 0.45.
How many shares outstanding does Danone SA ADR have?
Danone SA ADR has 3,416,685,800 shares outstanding.
What happened to Danone SA ADR’s price movement after its last earnings report?
Danone SA ADR reported an EPS of $0.437 in its last earnings report, beating expectations of $0.429. Following the earnings report the stock price went down -1.218%.
Which hedge fund is a major shareholder of Danone SA ADR?
Currently, no hedge funds are holding shares in DANOY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Danone SA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DANOY Sentiment 100%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 10.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.17%
12-Months-Change
Fundamentals
Return on Equity
11.34%
Trailing 12-Months
Asset Growth
8.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Danone SA ADR
Danone S.A. is a leading global enterprise in the food and beverage industry, with extensive operations spanning Europe, North America, Latin America, the Asia Pacific region, Africa, and the Middle East. The company's business is structured around three core segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Its Essential Dairy & Plant-Based segment encompasses a diverse portfolio of offerings, including yogurts, milk products, coffee creamers, various drinks and beverages, plant-based alternatives, ice creams, desserts, and nutritional powdered protein products. These are marketed under well-known proprietary brands such as Actimel, Activia, Alpro, and Danonino, as well as licensed brands like International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition division focuses on health-oriented products. This includes nutritional solutions for expectant and lactating mothers, infants, and young children, featuring brands like Aptamil, Nutrilon, and Happy Family Organics. Furthermore, it supplies clinical nutrition items such as tube feeding formulas (e.g., Nutrison) and oral nutritional supplements (e.g., Fortimel, NutriDrink). For children with allergies, Danone provides specialized hypoallergenic products under names like Aptamil ProSyneo and Neocate Syneo. Its Waters segment delivers a range of bottled waters, including natural mineral waters, those infused with fruit extracts, fruit juices, and vitamins, from popular brands such as evian, Volvic, Aqua, and Bonafont. Distribution of Danone's products occurs via a comprehensive multi-channel network, encompassing major retail chains, local market outlets, convenience stores, and specialized healthcare settings like hospitals, clinics, and pharmacies. The company also leverages e-commerce platforms to reach consumers. Founded in 1899, the company, originally known as Groupe Danone, adopted its current name, Danone S.A., in April 2009. Its corporate headquarters are located in Paris, France.
DANOY Company Deck
DANOY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly constructive picture: broad‑based organic growth across regions and categories, modest margin improvement at group level (+12 bps) and solid cash generation (EUR 0.9bn), alongside active M&A that enhances the health‑focused portfolio. These positives were tempered by legacy IMF recall effects, localized competitiveness issues in North America EDP (capacity constraints), timing‑related EDP margin pressure from inflation versus pricing, an intentional inventory build (~EUR 250m) that temporarily reduced near‑term free cash flow, and currency/refinancing headwinds. Management reiterated FY guidance and outlined concrete remediation and investment plans, signaling confidence in the recovery trajectory.View all DANOY earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors








